47.00USD+0.38%Mkt Cap: 2.14B $P/E: 106.821d ago
Omnicell, Inc., together with its subsidiaries, provides healthcare technology in the United States and internationally. It offers hospital and health systems solutions, such as points of care for clinician workflows in …
Industry Peers
Health Information Services$32.06BUSDP/E 35.0
$13.38BUSDP/E 88.5
$9.62BUSD
$8.27BUSDP/E 37.0
$6.65BUSD
$5.65BUSD
$4.44BUSDP/E 34.6
$3.43BUSDP/E 160.1
$2.24BUSD
$1.71BUSD
$1.41BUSD
$1.17BUSD
$1.13BUSD
$1.06BUSDP/E 52.0
$874.42MUSDP/E Infinity
$845.49MUSDP/E 43.2
$672.72MUSDP/E 68.1
$637.77MUSD
$581.77MUSDP/E 27.4
$584.81MUSD
$552.27MUSDP/E 13.1
$524.39MUSD
$516.62MUSD
$494.46MUSDP/E 56.3
$460.71MUSDP/E 25.8
$446.52MUSDP/E 25.4
$393.58MUSDP/E 90.5
$368.70MUSDP/E 45.6
$321.33MUSD
$230.81MUSDP/E 14.1
$224.12MUSDP/E 18.2
$217.63MUSD
$182.96MUSD
$156.35MUSDP/E 39.4
$168.48MUSD
$148.67MUSDP/E 29.6
$123.72MUSDP/E Infinity
$124.79MUSDP/E 18.5
$113.48MUSDP/E 25.4
$99.01MUSDP/E 17.9
$86.66MUSD
$65.63MUSDP/E 11.3
$62.29MUSDP/E 22.6
$57.34MUSD
$47.87MUSDP/E 57.6
$49.50MUSD
$40.55MUSDP/E 38.7
$39.14MUSD
$31.93MUSD
$26.93MUSDP/E 26.0
$22.91MUSDP/E 54.8
$20.17MUSD
$18.43MUSD
$12.99MUSD
$13.69MUSD
$12.35MUSD
$11.72MUSD
$9.78MUSDP/E 15.1
$6.67MUSD
$6.50MUSD
$5.63MUSD
$4.88MUSD
$3.78MUSDP/E Infinity
$3.83MUSDP/E 0.0
$3.40MUSD
$2.98MUSD
$2.70MUSD
$2.16MUSDP/E Infinity
$693.4KUSD
$548.9KUSDP/E 0.0
$282.6KUSD
—
—
CRY
GraniteShares YieldBOOST CRCL ETF—
—
EYES
Corgi Data & Surveillance ETF—P/E 30.8
Indicators:|
Key Statistics
Company
Market Cap2.14B $
Enterprise Value2.10B $
Revenue (TTM)1.23B $
Gross Profit503.44M $
Net Income (TTM)2.05M $
Revenue/Share26.84 USD
Last Price47.00 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees3.5K
CountryUS
SectorHealthcare
IndustryHealth Information Services
ISINUS68213N1090
Valuation
P/E (Trailing)106.82
P/E (Forward)21.41
PEG15.40
EV/EBITDA28.54
EV/Revenue1.71
P/S1.74
P/B1.70
EPS (TTM)0.44
EPS (Forward)2.19
52W Range
26.8572% of range55.00
52W High55.00 USD
52W Low26.85 USD
Profitability
Gross Margin42.49%
Oper. Margin5.44%
EBITDA Margin6.01%
Profit Margin0.17%
ROE0.17%
ROA0.10%
Growth
Revenue Growth14.90%
Earnings Growth—
Cash Flow & Leverage
Operating CF127.30M $
CapEx (TTM)57.93M $
FCF Margin9.19%
FCF Yield5.27%
Net Debt-37.04M $
Net Debt/EBITDA-0.50
Balance Sheet
Debt/Equity0.17
Current Ratio1.50
Quick Ratio1.04
Book Value/Sh27.63 USD
Cash/Share5.260 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.4 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)61.29 USD
Upside (mean)+30.4%
Target Range55.00 USD – 70.00 USD
$55.00+30.4% to mean$70.00
# Analysts7
Ownership
Shares Out.45.48M
Float41.94M
Insiders2.25%
Institutions105.35%
Short Interest
Short Ratio4.1d
Short % Float8.48%
Short % Out.6.99%
Shares Short3.18M
Short (prev mo.)2.97M
Technical
SMA 5042.54 (+10.5%)
SMA 20039.68 (+18.5%)
Beta0.97
S&P 52W Chg20.25%
Avg Vol (30d)663.46K
Avg Vol (10d)604.73K
Technical Indicators
RSI (14)67.1
MACD1.5405
MACD Signal0.9239
MACD Hist.+0.6166
BB Upper48.67 USD
BB Middle42.38 USD
BB Lower36.09 USD
BB Width29.68%
ATR (14)1.863 USD
Vol Ratio (20d)0.60x